38410123|t|Silibinin suppresses glioblastoma cell growth, invasion, stemness, and glutamine metabolism by YY1/SLC1A5 pathway.
38410123|a|Background: Silibinin has been found to inhibit glioblastoma (GBM) progression. However, the underlying molecular mechanism by which Silibinin regulates GBM process remains unclear. Methods: GBM cell proliferation, apoptosis, invasion, and stemness are assessed by cell counting kit-8 assay, EdU assay, flow cytometry, transwell assay, and sphere formation assay. Western blot is used to measure the protein expression levels of apoptosis-related markers, solute carrier family 1 member 5 (SLC1A5), and Yin Yang-1 (YY1). Glutamine consumption, glutamate production, and alpha-ketoglutarate production are detected to evaluate glutamine metabolism in cells. Also, SLC1A5 and YY1 mRNA levels are examined using quantitative real-time PCR. Chromatin immunoprecipitation assay and dual-luciferase reporter assay are used to detect the interaction between YY1 and SLC1A5. Mice xenograft models are constructed to explore Silibinin roles in vivo. Results: Silibinin inhibits GBM cell proliferation, invasion, stemness, and glutamine metabolism, while promotes apoptosis. SLC1A5 is upregulated in GBM and its expression is decreased by Silibinin. SLC1A5 overexpression abolishes the anti-tumor effect of Silibinin in GBM cells. Transcription factor YY1 binds to SLC1A5 promoter region to induce SLC1A5 expression, and the inhibition effect of YY1 knockdown on GBM cell growth, invasion, stemness, and glutamine metabolism can be reversed by SLC1A5 overexpression. In addition, Silibinin reduces GBM tumor growth by regulating YY1/SLC1A5 pathway. Conclusion: Silibinin plays an anti-tumor role in GBM process, which may be achieved via inhibiting YY1/SLC1A5 pathway.
38410123	21	33	glioblastoma	Disease	MESH:D005909
38410123	71	80	glutamine	Chemical	MESH:D005973
38410123	95	98	YY1	Gene	22632
38410123	99	105	SLC1A5	Gene	20514
38410123	163	175	glioblastoma	Disease	MESH:D005909
38410123	177	180	GBM	Disease	MESH:D005909
38410123	268	271	GBM	Disease	MESH:D005909
38410123	306	309	GBM	Disease	MESH:D005909
38410123	571	603	solute carrier family 1 member 5	Gene	20514
38410123	605	611	SLC1A5	Gene	20514
38410123	618	628	Yin Yang-1	Gene	22632
38410123	630	633	YY1	Gene	22632
38410123	636	645	Glutamine	Chemical	MESH:D005973
38410123	659	668	glutamate	Chemical	MESH:D018698
38410123	685	704	alpha-ketoglutarate	Chemical	MESH:D007656
38410123	741	750	glutamine	Chemical	MESH:D005973
38410123	778	784	SLC1A5	Gene	20514
38410123	789	792	YY1	Gene	22632
38410123	966	969	YY1	Gene	22632
38410123	974	980	SLC1A5	Gene	20514
38410123	982	986	Mice	Species	10090
38410123	1084	1087	GBM	Disease	MESH:D005909
38410123	1132	1141	glutamine	Chemical	MESH:D005973
38410123	1180	1186	SLC1A5	Gene	20514
38410123	1205	1208	GBM	Disease	MESH:D005909
38410123	1255	1261	SLC1A5	Gene	20514
38410123	1296	1301	tumor	Disease	MESH:D009369
38410123	1325	1328	GBM	Disease	MESH:D005909
38410123	1357	1360	YY1	Gene	22632
38410123	1370	1376	SLC1A5	Gene	20514
38410123	1403	1409	SLC1A5	Gene	20514
38410123	1451	1454	YY1	Gene	22632
38410123	1468	1471	GBM	Disease	MESH:D005909
38410123	1509	1518	glutamine	Chemical	MESH:D005973
38410123	1549	1555	SLC1A5	Gene	20514
38410123	1603	1612	GBM tumor	Disease	MESH:D005909
38410123	1634	1637	YY1	Gene	22632
38410123	1638	1644	SLC1A5	Gene	20514
38410123	1690	1695	tumor	Disease	MESH:D009369
38410123	1704	1707	GBM	Disease	MESH:D005909
38410123	1754	1757	YY1	Gene	22632
38410123	1758	1764	SLC1A5	Gene	20514
38410123	Association	MESH:D005973	20514
38410123	Positive_Correlation	20514	22632
38410123	Association	MESH:D005909	20514
38410123	Association	MESH:D005973	MESH:D005909
38410123	Association	MESH:D005973	22632
38410123	Association	MESH:D005909	22632

